Suggestions
Rod Minchin
Professor of Molecular Pharmacology at The University of Queensland
Dr. Rod Minchin, a distinguished researcher, is currently the Professor of Molecular Pharmacology at the University of Queensland. He obtained his PhD in Pharmacology from the University of Western Australia and later pursued post-doctoral studies in pulmonary drug metabolism at Washington DC under the guidance of Dr. Michael Boyd.
Dr. Minchin's academic journey includes working as a QEII fellow at the University of New South Wales with Prof. Denis Wade, focusing on polyamine biochemistry and drug targeting to the lungs. He then returned to the University of Western Australia before assuming the prestigious Chair of Molecular Pharmacology at the University of Queensland in Brisbane.
His primary research interests revolve around drug metabolism and its implications for disease susceptibility, particularly in the context of cancer. Dr. Minchin's notable work has delved into understanding the significance of acetyltransferases in cancer risk, exploring their genetic factors and variations in malignant conditions. Additionally, he has conducted research on the regulation of cytosolic sulfotransferases and their involvement in neurodegenerative disorders.
In recent years, Dr. Minchin has engaged in collaborative projects with chemists and material scientists to pioneer the development of nanomaterials for biomedical applications. This collaborative effort aims to investigate the uptake, intracellular localization, and interactions of nanoparticles with circulating proteins to enhance our understanding of their safety profile.
